Abstract
Objective: We aimed to compare time spent at low glucose level (silent hypoglycemia, glucose <3.0 mmol/l) and glycemic variability in patients who reached HbA1c <7.0% with those who did not.
Research Design and Methods: In 108 type 2 diabetic patients the interstitial glucose concentration was measured with CGMS (Continuous Glucose Monitoring System) over 72 h. Patients were divided in group 1 with an HbA1c <7.0% (n=63) and group 2 with an HbA1c≥7.0% (n=45).
Results: 24% in group 1 experienced silent hypoglycemia vs. 11% in group 2 (n. s.), duration of silent hypoglycemia over 48 h was 27±71 min vs. 7±36 min (n. s.). This was also valid for the subgroups treated with insulin. Patients in group 2 had a significantly higher standard deviation of average glucose (2.3±0.8 vs. 1.3±0.6; p<0.001) and MAGE (mean amplitude of glycemic excursions) (4.8±2.1 vs. 2.6±1.1; p<0.001).
Conclusion: Silent hypoglycemia tended to occur more often and to last longer in patients with HbA1c <7%. However, patients with HbA1c >7% had a higher glycemic variability. HbA1c >7% wasn’t a reliable indicator of lower risk of hypoglycemia.
Key words
CGMS - hypoglycemia - glycemic variability
References
-
1
Action to Control Cardiovascular Risk in Diabetes Study Group.
.
Gerstein HC,, Miller ME, Byington RP. et al .
Effects of intensive glucose lowering in type 2 diabetes.
N Engl J Med.
2008;
358
(24)
2545-2559
-
2
American Diabetes Association.
.
Standards of Medical Care in Diabetes – 2009.
Diabetes Care.
2009;
32
(Suppl. 1)
13-61
-
3
Desouza C, Salazar H, Cheong B. et al .
Association of hypoglycemia and cardiac ischemia.
Diabetes Care.
2003;
26
1485-1489
-
4
Gill GV, Woodward A, Casson IF. et al .
Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes – the ‘dead in bed’ syndrome revisited.
Diabetologia.
2009;
52
42-45
-
5
Hanefeld M, Koehler C, Hoffmann C. et al .
Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early type 2 diabetes.
Diabetic medicine.
2010;
27
175-180
-
6
Hirsch IB.
Glycemic Variability: It's not just about A1c anymore.
Diabetes Technology & Therapeutics.
2005;
7
780-783
-
7
Holman RR, Farmer AJ, Davies MJ. et al .
4-T Study Group: Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes.
N Engl J Med.
2009;
361
1736-1747
-
8
Monnier L, Mas E, Ginet C. et al .
Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.
JAMA.
2006;
295
1681-1687
-
9
Kosiborod M, Inzucchi SE, Goyal A. et al .
Relationship between spontaneous and iatrogenic hypoglycaemia in patients hospitalized with acute myocardial infarction.
JAMA.
2009-07-10;
301
1556-1564
-
10
Service FJ, Molnar GD, Rosevear JW. et al .
Mean amplitudes of glycemic excursions, a measure of diabetes instability.
Diabetes.
1970;
19
(9)
644-655
Correspondence
M. Hanefeld
GWT-TUD GmbH
Center for clinical studies
Fiedlerstraße 34
01307 Dresden
Germany
Telefon: + 49/351/4400 580
Fax: + 49/351/4400 581
eMail: hanefeld@gwtonline-zks.de
